BMT CTN 1507

Official Title

Reduced Intensity Conditioning for Haploidentical Bone Marrow Transplantation in Patients with Symptomatic Sickle Cell Disease

Study Details

The purpose of the study is to see if a new type of allogeneic transplant (bone marrow transplant) called a haploidentical transplant is safe and effective to treat SCD (Sickle Cell Disease).

Principal Investigator

Dr. Shalini Shenoy

IRB Number



1. Participants must be 5 to 45 years of age
2. Participants must have severe SCD

Volunteer Information

For more information about this study, contact Volunteer for Health at: